ART DECO
Disease site: Head and Neck
Treatment Modality: Radiotherapy
Status: Open to recruitment
A phase III multi-centre randomised controlled trial to determine the potential of dose escalated IMRT to improve locoregional failure free rate (LRFFR) and laryngeal preservation in patients with locally advanced laryngeal and hypopharyngeal cancers, without increasing the incidence of severe acute and late toxicities to unacceptable levels.
Chief Investigator: | Dr Chris Nutting |
Sponsor: | The Royal Marsden NHS Foundation Trust |
Source of funding: | Cancer Research UK |
ISRCTN: | 1483375 |
In the Clinical Trials Section
